Related Experiment Video
Updated: Dec 29, 2025

08:54
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
14.3K
Scavenger Receptor Class A to E Involved in Various Cancers
Sunhyo Ryu1, Amanda Howland2, Brendon Song3
1Boston University School of Medicine, Boston, MA, USA.
Chonnam Medical Journal
|February 6, 2020
Summary
Scavenger receptors, involved in cellular defense, are increasingly linked to cancer. This review focuses on scavenger receptor classes A-E and their roles in cancer progression.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Scavenger receptors (SRs) are cell surface receptors that bind various ligands, including self and non-self molecules.
- SRs mediate the clearance of harmful substances via endocytosis and phagocytosis.
- SRs are classified into eight distinct classes based on sequence variations.
Purpose of the Study:
- To review the current understanding of scavenger receptor classes A through E.
- To explore the emerging roles of these SR classes in cancer progression and carcinogenesis.
- To highlight the potential of targeting SRs for cancer prognosis.
Main Methods:
- Literature review of recent studies on scavenger receptors and cancer.
- Focus on scavenger receptor classes A, B, C, D, and E.
- Analysis of the association between SRs and cancer hallmarks.
Main Results:
- Scavenger receptors play diverse roles in cancer, influencing inflammation, immune evasion, and tumor growth.
- Specific SR classes (A-E) exhibit distinct associations with various cancer types and stages.
- Evidence suggests SRs can act as both promoters and inhibitors of cancer progression.
Conclusions:
- Scavenger receptor classes A-E are implicated in cancer development and progression.
- Targeting scavenger receptors presents a potential therapeutic strategy for improving cancer prognosis.
- Further research is warranted to fully elucidate the complex roles of SRs in oncology.
Related Concept Videos
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.5K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
Selectins
4.0K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.0K
Rous Sarcoma Virus (RSV) and Cancer
6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.0K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

